GLP1R and cholangiocarcinoma: For instance, GLP-1R agonists like liraglutide have been shown to slow the progression of cholangiocarcinoma by inhibiting cell migration and reducing tumor growth, despite the association of GLP-1R expression with poor histological grading in intrahepatic cholangiocarcinoma tissues [10].